期刊文献+

缬沙坦对不同浓度C-反应蛋白诱导的单核细胞白细胞介素-6合成的影响 被引量:2

Effect of valsartan on interleukin-6 synthesis in monocytes stimulated by C-reactive protein
下载PDF
导出
摘要 目的通过研究缬沙坦对C-反应蛋白(CRP)诱导的正常人外周血单核细胞合成白细胞介素-6(IL-6)的影响,观察缬沙坦的抗炎作用。方法采用密度梯度离心法分离人外周血单核细胞,应用酶联免疫吸附试验分别观察CRP(15、、10及20 mg/L)刺激单核细胞产生IL-6的时间及剂量效应,其峰值与缬沙坦抑制剂进行比较。结果CRP刺激单核细胞IL-6合成呈时间依赖性和剂量依赖性,20 mg/L CRP与5 mg/L CRP诱导IL-6合成开始的时间是4 h,在24 h达高峰,其峰值分别是(904±77)ng/L和(698±52)ng/L。高浓度缬沙坦(≥10-3mol/L)能抑制20 mg/LCRP诱导的单核细胞IL-6合成,较低浓度缬沙坦(1×10-6mol/L^1×10-3mol/L)能抑制5 mg/L CRP诱导的单核细胞IL-6合成。结论缬沙坦可用于轻度炎症时抗细胞因子治疗。 Objectives To evaluate the effect of valsartan on interleukin-6 production in human monocytes stimulated by C-reactive protein(CRP) and to assess the influence of valsartan on monocyte inflammatory reaction. Methods Monocytes were isolated by Fieoll density gradient from blood of healthy volunteers. IL-6 produetion (by ELISA) in monocytes stimulated by 20 mg/L and 5 mg/L CRP was measured at 2 h , 4 h,8 h, 16 h and 24 h. The peak value was compared with IL-6 produced by the monocytes inhibited by valsartan ( 1 × 10^-6 mol/L~ 1 × 10^-3 mol/L).Results IL-6 began to be synthesized by monocytes stimulated by CRP after stimulation for 4 h. The effect of CRP was dose-dependent and time-dependent, reaching peak at 24 h. The highest levels of monocytes IL-6 were 904 ± 77 and 698 ± 52 ng/L in 20 mg/L and 5 mg/L CRP groups, respectively. Valsartan( 1 × 10^-3 mol/L) inhibited IL-6 production induced by 20 mg/L CRP and valsartan( 1 × 10^-6 mol/L- 1 × 10-3 mol/L)could inhibit IL-6 production induced by 5 mg/L CRP. Conclusion Valsaaan could be used in anticytokine therapeutic strategy in low-grade inflammation.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2005年第4期263-265,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 长江大学科研基金(200304)
关键词 缬沙坦 C反应蛋白质 白细胞介素6 单核细胞 炎症 valsartan C-reactive protein interleukin-6 monocytes inflammation
  • 相关文献

参考文献6

  • 1Ross R. Atherosclerosis-an inflammatory disease[J]. N Engl J Med,1999,340:115-126.
  • 2Watanabe S, Mu W, Kahn A, et al . Role of JAK/STAT pathway in IL6-induced activation of vasctflar smooth rtmscle eens [ J ]. Am J Nephrol, 2004, 24: 387-392.
  • 3Mazer SP, Rabbani LE. Evidence for C-reactive protein's role in(CRP) vascular disease: Atherothrombosis, immmo-regulation and CRP[J]. J Thromb Thrombolysis,2004, 17:95-105.
  • 4Wu L, Iwai M, Nakagami H, et al . Roles of angiotensin Ⅱ type 2 receptor stimulation associated with selective angiotensin Ⅱ type 1 receptor blockade with valsartan in the improvement of inflananation-induced vascular injury[J]. Circulation,2001,104:2716-2721.
  • 5Yudkin JS, Kumari M, Hmnphries SE, et al . Inflammation, obesity,stress and coronary heart disease: is interldukin-6 the link[J]? Atherosclerosis, 2000, 148:209-214.
  • 6Schiffrin EL. Beyond blood pressttre: the endothelium and atheroscleroe, is progression [ J ]. American Journal of Hypertension, 2002, 15 :115S-122S.

同被引文献6

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部